Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer. (Q51368192)
Jump to navigation
Jump to search
scientific article published on 15 September 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer. |
scientific article published on 15 September 2011 |
Statements
Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer. (English)
1 reference
Yves Cottin
1 reference
Alexandre Cochet
1 reference
Gaetan Quilichini
1 reference
Inna Dygai-Cochet
1 reference
Claude Touzery
1 reference
Michel Toubeau
1 reference
Alina Berriolo-Riedinger
1 reference
Pierre Fumoleau
1 reference
François Brunotte
1 reference
15 September 2011
1 reference
130
1 reference
3
1 reference
845-854
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference